Regeneron

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

1 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Global Markets & Equities Just now (03:11 AM IST)

Kodiak Shares Soar After Phase 3 Data Show Two Eye Drugs Hit Key Endpoints

Kodiak Sciences surged in early trading after reporting positive late-stage results for two ophthalmology candidates, including a wet age-related macular degeneration treatment that matched the standard-setting drug Eylea in a pivotal study. The readout revived investor confidence in a company that has spent years under pressure and sharply improved the commercial prospects for its eye-disease franchise.

By RDU Global Wire4 min read

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Regeneron:

Washington, D.C.(1)Kodiak Sciences(1)Bayer(1)